Delivery Order SPE2DB24D2101-SPE2DB25FKNUT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,298,778 potassium chloride extended-release tablets in packages of 500. The contract has a ceiling value of $1,349.95 and a completion date of April 17, 2024. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent capsules in quantities of 500, with a ceiling value of $1,146.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500-count containers) under a firm fixed-price contract with a ceiling value of $1,544.08. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $3,143.33 delivery order to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 18, 2025. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- This federal contract award, valued at $2,149.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,142,826 potassium chloride extended-release tablets, 500 tablets per bottle. The contract is not set aside and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500 count) valued at $1,024.41, with completion scheduled for August 1, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $1,146.36 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Potassium Chloride 10 milliequivalents per 100 milliliters solution in 100-milliliter units. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNUTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for potassium chloride extended-release 8 milliequivalent tablets (500 count) on August 22, 2025, with a ceiling value of $1,543.91 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/22/25 |